Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Holders of 5% or more of ACON
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aclarion, Inc., largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Aclarion, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 20268:44 PM ET | SEG Opportunity Fund, LLC | 13G | 9.98%244.0K shares | New | Mar 25, 2026 | SEC |
| Feb 13, 20256:04 PM ET | SEG Opportunity Fund, LLC | 13G/A | 0.00%0 shares | –Below 5% | Feb 13, 2025 | SEC |
| Jan 21, 20254:25 PM ET | SEG Opportunity Fund, LLC | 13G | 9.90%4.40M shares | New | Jan 15, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aclarion, Inc. shares.
No Form 144 notices for Aclarion, Inc. are on file.